Clinical trials
Mycoses trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 5 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Astellas Pharma Inc | 2 |
| 958th Army Hospital of the Chinese People's Liberation Army | 1 |
| Basilea Pharmaceutica | 1 |
| Children's Hospital of Fudan University | 1 |
| Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 1 |
| Cttq | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Peking University First Hospital | 1 |
| Ruijin Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mycoses | 16 |
| Candidemia | 3 |
| Candidiasis, Invasive | 3 |
| Bacterial Infections | 2 |
| Fungemia | 2 |
| Invasive Fungal Infections | 2 |
| Sepsis | 2 |
| Acute Kidney Injury | 1 |
| Acute-On-Chronic Liver Failure | 1 |
| Adenoviridae Infections | 1 |
Trials
Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.